Point State Capital LP Novo Nordisk A S Transaction History

Point State Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $4.79 Million - $5.85 Million	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $4.22 Million - $5.33 Million	50,000 New	50,000 $4.8 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $1.37 Million - $1.58 Million	-21,386 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $2.94 Million - $3.24 Million	-46,114 Reduced 68.32%	21,386 $1.49 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $3.95 Million - $4.59 Million	67,500 New	67,500 $4.42 Million

Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $2.87 Million - $3.22 Million	-60,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $1.7 Million - $1.91 Million	-36,400 Reduced 37.64%	60,300 $3.08 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $4.48 Million - $5.09 Million	96,700 New	96,700 $5.06 Million

1,861

310M

5.29M

4.93M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $321B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.